Randomized Exercise Trial of Aromatase Inhibitor–Induced Arthralgia in Breast Cancer Survivors

PURPOSE: Arthralgia occurs in up to 50% of breast cancer survivors treated with aromatase inhibitors (AIs) and is the most common reason for poor AI adherence. We conducted, in 121 breast cancer survivors receiving an AI and reporting arthralgia, a yearlong randomized trial of the impact of exercise...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Oncol
Autors principals: Irwin, Melinda L., Cartmel, Brenda, Gross, Cary P., Ercolano, Elizabeth, Li, Fangyong, Yao, Xiaopan, Fiellin, Martha, Capozza, Scott, Rothbard, Marianna, Zhou, Yang, Harrigan, Maura, Sanft, Tara, Schmitz, Kathryn, Neogi, Tuhina, Hershman, Dawn, Ligibel, Jennifer
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2015
Matèries:
ORIGINAL REPORTS
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4372849/
https://ncbi.nlm.nih.gov/pubmed/25452437
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.57.1547
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars